Onset of Action and Peak Effect Timing

Onset of action is the interval between drug exposure and the first detectable effect, and the time to peak effect is when that effect reaches its maximum. Both are temporal properties of pharmacodynamics: they depend not only on how fast the drug reaches its site of action but also on how the response itself is generated, so the peak effect frequently occurs later than the peak plasma concentration.

Definition

Onset of action is the time from drug administration to the first measurable pharmacological effect, and time to peak effect is the time from administration to the maximum effect; together they characterise the rising phase of the drug's time-effect curve.

Scope

This topic covers what determines when a drug effect begins and when it crests, the lag (hysteresis) between concentration and effect, and the effect-compartment framework used to model that lag. It is a reference treatment of temporal pharmacodynamics and does not provide dosing schedules or treatment timing advice.

Core questions

• What determines how quickly a drug effect begins after exposure?
• Why does the peak effect often occur after the peak plasma concentration?
• How is the delay between concentration and effect modelled quantitatively?

Key concepts

• Onset of action
• Time to peak effect
• Effect-site equilibration
• Concentration-effect hysteresis
• Rate of absorption and distribution
• Stimulus-response transduction delay

Key theories

Effect-compartment (link) model

Modelling effect as driven by a hypothetical effect-site concentration linked to plasma by a first-order equilibration rate constant explains why onset and peak effect lag the plasma concentration, and the magnitude of the rate constant determines how quickly the effect site equilibrates and therefore how soon the peak occurs.

Mechanisms

Onset and peak timing reflect how fast the active concentration builds at the site of action and how that concentration is transduced into a measurable response. Rapid absorption and distribution shorten onset, while slow equilibration between plasma and the effect site delays the peak. Because the response may also be a downstream consequence of receptor binding rather than the binding itself, the effect can continue to rise after the plasma concentration has begun to fall, producing a counter-clockwise hysteresis loop when effect is plotted against concentration. The effect-compartment model captures this by interposing a first-order equilibration step between plasma and effect, so the modelled effect-site concentration peaks later than plasma; the equilibration rate constant sets the timing of the peak effect.

Clinical relevance

Onset and peak-effect timing describe when an observed drug effect can be expected to appear and to be maximal, which is part of how pharmacology interprets the time course of responses and adverse effects. These concepts are presented for reference and education and are not instructions for the timing or scheduling of any individual's treatment.

Evidence & guidelines

The quantitative account of onset and peak timing rests on pharmacokinetic-pharmacodynamic modelling, particularly the effect-compartment analysis of Sheiner and colleagues and the Holford and Sheiner reviews; the concepts are also standard in pharmacology textbooks. There are no clinical guidelines specific to this temporal topic.

History

The observation that effect can lag concentration was made quantitative when Sheiner and colleagues introduced the effect-compartment model in 1979 to describe the delayed neuromuscular effect of d-tubocurarine. Holford and Sheiner then generalised the kinetics of pharmacologic response in their 1981 and 1982 reviews, giving onset and peak timing a formal place within pharmacodynamics.

Key figures

• Lewis B. Sheiner
• Nicholas H. G. Holford
• Donald R. Stanski

Seminal works

• sheiner-1979
• holford-sheiner-1981
• holford-sheiner-1982

Frequently asked questions

Why is the peak effect of a drug often later than its peak blood concentration?

The effect is driven by the concentration at the site of action and by downstream responses, which take time to equilibrate with the plasma; this lag means the modelled effect-site concentration, and therefore the effect, peaks after the plasma concentration.

Does a faster onset mean a stronger effect?

No. Onset describes when an effect begins, not how large it is; a drug can have a rapid onset with a modest maximum effect, or a slow onset with a large one, because timing and magnitude are governed by different properties.